CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for plastics, chemicals and energy, today announced that Lynne H. Brum has joined the company as vice president of marketing and corporate communications and a member of the executive management team. Ms. Brum is responsible for overseeing all aspects of the company’s marketing and corporate communications initiatives.
“Her communications expertise in the life sciences industry will be a valuable asset to the company as we build awareness across our bioplastic, chemical and crop platforms.”
“Lynne brings a passion for both science and communications to her role at Metabolix,” said Richard P. Eno, president and CEO of Metabolix. “Her communications expertise in the life sciences industry will be a valuable asset to the company as we build awareness across our bioplastic, chemical and crop platforms.”
Ms. Brum has more than 20 years of experience leading communications programs for technology-based life science companies. Prior to joining Metabolix, she served as an executive vice president at Porter Novelli Life Sciences — a subsidiary of global PR firm, Porter Novelli International. Prior to that, Ms. Brum was responsible for corporate communications, investor relations and brand management in her role as vice president of strategic communications for Vertex Pharmaceuticals, Inc. Ms. Brum was also a vice president at Feinstein Kean Healthcare and was part of the communications team at Biogen, Inc. (now Biogen Idec).
Ms. Brum holds a bachelor’s degree in biological sciences from Wellesley College and a master’s degree in business administration from Simmons College’s School of Management.
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience company focused on providing sustainable solutions for the world’s needs for plastics, chemicals and energy. The Company is taking a systems approach, from gene to end product, integrating sophisticated biotechnology with advanced industrial practice. Metabolix is now developing and commercializing Mirel™, a family of high performance bioplastics which are biobased and biodegradable alternatives to many petroleum-based plastics, through Telles, a joint venture of Metabolix and Archer Daniels Midland Company. Metabolix is also developing biosourced industrial chemicals and a proprietary platform technology for co-producing plastics, chemicals and energy, from crops such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com. (MBLX-G)